tiprankstipranks
Naturhouse Health (GB:0R9G)
LSE:0R9G
UK Market
0R9G
Naturhouse Health
RESEARCH TOOLSreports

Naturhouse Health (0R9G) Ratios

1 Followers

Naturhouse Health Ratios

GB:0R9G's free cash flow for Q2 2025 was €0.73. For the 2025 fiscal year, GB:0R9G's free cash flow was decreased by € and operating cash flow was €0.31. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 2.12 1.65 4.36 2.69 3.23
Quick Ratio
 1.90 1.40 3.83 2.48 2.91
Cash Ratio
 1.61 1.13 3.20 1.91 1.44
Solvency Ratio
 0.47 0.72 1.08 0.74 0.80
Operating Cash Flow Ratio
 0.70 1.02 1.79 1.64 0.85
Short-Term Operating Cash Flow Coverage
 0.00 24.59 93.98 145.49 21.84
Net Current Asset Value
€ 11.75M€ 3.92M€ 17.27M€ 16.16M€ 12.11M
Leverage Ratios
Debt-to-Assets Ratio
 0.06 0.10 0.10 0.10 0.13
Debt-to-Equity Ratio
 0.11 0.19 0.13 0.16 0.19
Debt-to-Capital Ratio
 0.10 0.16 0.12 0.14 0.16
Long-Term Debt-to-Capital Ratio
 0.04 0.14 0.03 0.05 0.06
Financial Leverage Ratio
 1.69 1.88 1.34 1.59 1.54
Debt Service Coverage Ratio
 61.73 18.63 45.62 54.85 22.83
Interest Coverage Ratio
 80.83 151.25 94.60 152.00 62.39
Debt to Market Cap
 <0.01 0.03 0.01 0.02 0.02
Interest Debt Per Share
 0.05 0.06 0.07 0.09 0.09
Net Debt to EBITDA
 -1.80 -0.70 -1.05 -1.08 -0.43
Profitability Margins
Gross Profit Margin
72.34%27.17%71.75%49.81%71.53%
EBIT Margin
28.76%27.95%27.68%31.09%25.40%
EBITDA Margin
29.42%30.33%31.63%35.58%29.78%
Operating Profit Margin
28.55%27.95%26.60%32.27%24.53%
Pretax Profit Margin
29.75%28.75%27.40%30.58%25.00%
Net Profit Margin
22.13%21.19%19.96%22.40%18.37%
Continuous Operations Profit Margin
22.13%21.19%19.96%22.31%18.36%
Net Income Per EBT
74.40%73.71%72.83%73.26%73.47%
EBT Per EBIT
104.18%102.89%102.99%94.78%101.95%
Return on Assets (ROA)
18.78%30.19%23.16%23.12%22.48%
Return on Equity (ROE)
29.55%56.86%31.13%36.87%34.62%
Return on Capital Employed (ROCE)
35.58%61.75%36.39%45.07%37.34%
Return on Invested Capital (ROIC)
25.65%44.50%25.79%31.56%26.25%
Return on Tangible Assets
18.93%30.53%23.36%23.33%22.81%
Earnings Yield
5.02%7.73%9.91%11.63%10.16%
Efficiency Ratios
Receivables Turnover
 13.28 22.65 20.97 20.05 21.81
Payables Turnover
 2.20 15.12 3.85 6.18 4.42
Inventory Turnover
 3.35 11.89 4.05 9.19 5.59
Fixed Asset Turnover
 12.18 18.37 14.83 13.75 13.17
Asset Turnover
 0.85 1.42 1.16 1.03 1.22
Working Capital Turnover Ratio
 2.37 3.24 2.28 2.50 2.19
Cash Conversion Cycle
 -29.11 22.67 12.65 -1.12 -0.56
Days of Sales Outstanding
 27.49 16.12 17.41 18.20 16.74
Days of Inventory Outstanding
 109.04 30.69 90.06 39.72 65.29
Days of Payables Outstanding
 165.64 24.14 94.82 59.04 82.59
Operating Cycle
 136.53 46.81 107.47 57.92 82.03
Cash Flow Ratios
Operating Cash Flow Per Share
 0.16 0.20 0.19 0.35 0.12
Free Cash Flow Per Share
 0.15 0.19 0.19 0.34 0.10
CapEx Per Share
 0.01 0.01 <0.01 <0.01 0.02
Free Cash Flow to Operating Cash Flow
 0.93 0.95 0.97 0.97 0.86
Dividend Paid and CapEx Coverage Ratio
 1.01 0.65 0.94 3.19 0.37
Capital Expenditure Coverage Ratio
 14.11 18.24 34.20 36.75 7.36
Operating Cash Flow Coverage Ratio
 3.60 3.62 2.71 4.15 1.32
Operating Cash Flow to Sales Ratio
 0.26 0.26 0.23 0.42 0.14
Free Cash Flow Yield
5.75%8.79%11.28%20.98%6.47%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 19.91 12.94 10.09 8.60 9.84
Price-to-Sales (P/S) Ratio
 4.27 2.74 2.01 1.93 1.81
Price-to-Book (P/B) Ratio
 6.33 7.36 3.14 3.17 3.41
Price-to-Free Cash Flow (P/FCF) Ratio
 17.38 11.38 8.87 4.77 15.44
Price-to-Operating Cash Flow Ratio
 16.67 10.75 8.61 4.64 13.35
Price-to-Earnings Growth (PEG) Ratio
 0.20 2.07 -0.64 0.46 -0.36
Price-to-Fair Value
 6.33 7.36 3.14 3.17 3.41
Enterprise Value Multiple
 12.70 8.35 5.32 4.34 5.64
Enterprise Value
 138.61M 120.55M 83.11M 77.78M 87.99M
EV to EBITDA
 12.70 8.35 5.32 4.34 5.64
EV to Sales
 3.74 2.53 1.68 1.54 1.68
EV to Free Cash Flow
 15.22 10.50 7.41 3.82 14.35
EV to Operating Cash Flow
 14.14 9.93 7.19 3.71 12.40
Tangible Book Value Per Share
 0.41 0.29 0.52 0.50 0.45
Shareholders’ Equity Per Share
 0.42 0.30 0.53 0.51 0.46
Tax and Other Ratios
Effective Tax Rate
 0.26 0.26 0.27 0.27 0.27
Revenue Per Share
 0.60 0.80 0.82 0.84 0.87
Net Income Per Share
 0.13 0.17 0.16 0.19 0.16
Tax Burden
 0.74 0.74 0.73 0.73 0.73
Interest Burden
 1.03 1.03 0.99 0.98 0.98
Research & Development to Revenue
 0.00 0.00 <0.01 <0.01 <0.01
SG&A to Revenue
 0.24 0.00 0.21 0.20 0.21
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 1.19 1.20 0.85 1.86 0.54
Currency in EUR